HRP20070353T3 - Extended release coated minitablets of venlafaxine hydrochloride - Google Patents

Extended release coated minitablets of venlafaxine hydrochloride

Info

Publication number
HRP20070353T3
HRP20070353T3 HR20070353T HRP20070353T HRP20070353T3 HR P20070353 T3 HRP20070353 T3 HR P20070353T3 HR 20070353 T HR20070353 T HR 20070353T HR P20070353 T HRP20070353 T HR P20070353T HR P20070353 T3 HRP20070353 T3 HR P20070353T3
Authority
HR
Croatia
Prior art keywords
venlafaxine hydrochloride
tablets
extended release
mini
release coated
Prior art date
Application number
HR20070353T
Other languages
English (en)
Croatian (hr)
Inventor
Bhattacharya Sampad
Kshirsagar Rajesh
Joshi Mayank
Pandita Sandeep
Original Assignee
Alembic Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alembic Limited filed Critical Alembic Limited
Publication of HRP20070353T3 publication Critical patent/HRP20070353T3/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HR20070353T 2004-02-04 2007-08-08 Extended release coated minitablets of venlafaxine hydrochloride HRP20070353T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN117MU2004 2004-02-04
IN980MU2004 2004-09-13
PCT/IN2004/000340 WO2005074895A1 (fr) 2004-02-04 2004-10-27 Micro-comprimes revetus a liberation prolongee de chlorhydrate de venlafaxine

Publications (1)

Publication Number Publication Date
HRP20070353T3 true HRP20070353T3 (en) 2008-01-31

Family

ID=34809925

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20070353T HRP20070353T3 (en) 2004-02-04 2007-08-08 Extended release coated minitablets of venlafaxine hydrochloride

Country Status (24)

Country Link
US (1) US7807195B2 (fr)
EP (1) EP1711169B1 (fr)
JP (1) JP2007520547A (fr)
KR (1) KR20070000439A (fr)
AT (1) ATE361743T1 (fr)
AU (1) AU2004315136B2 (fr)
BR (1) BRPI0418283A (fr)
CA (1) CA2555295C (fr)
CY (1) CY1106741T1 (fr)
DE (1) DE602004006443T2 (fr)
DK (1) DK1711169T3 (fr)
ES (1) ES2287813T3 (fr)
HK (1) HK1091137A1 (fr)
HR (1) HRP20070353T3 (fr)
IL (1) IL177243A0 (fr)
MX (1) MXPA06008854A (fr)
NO (1) NO20063809L (fr)
NZ (1) NZ548504A (fr)
PL (1) PL1711169T3 (fr)
PT (1) PT1711169E (fr)
RU (1) RU2340331C2 (fr)
SI (1) SI1711169T1 (fr)
UA (1) UA82597C2 (fr)
WO (1) WO2005074895A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL146462A (en) 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
WO2004047718A2 (fr) * 2002-11-28 2004-06-10 Themis Laboratories Private Limited Procede de fabrication de microperles a liberation prolongee contenant de la venlafaxine hci
WO2006136927A1 (fr) * 2005-06-22 2006-12-28 Glenmark Pharmaceuticals Limited Preparation a liberation prolongee comprenant de la venlafaxine
EP1906935A4 (fr) * 2005-07-28 2010-10-20 Reddys Lab Ltd Dr Compositions de venlafaxine à diffusion étendue
US20090175934A1 (en) * 2006-03-08 2009-07-09 Jubilant Organosys Ltd. Extended Release Pharmaceutical Formulation of Venlafaxine and Method of Manufacturing the Same
WO2007112574A1 (fr) * 2006-04-03 2007-10-11 Isa Odidi Composition de venlafaxine à libération prolongée
CN101453996B (zh) * 2006-04-03 2016-05-11 伊萨·奥迪迪 药物递送组合物
WO2007129329A2 (fr) * 2006-05-08 2007-11-15 Jubilant Organosys Limited Préparation pharmaceutique à libération prolongée comprenant du chlorhydrate de venlafaxine
WO2008074144A1 (fr) * 2006-12-20 2008-06-26 Genpharm Ulc Composition contenant un acide bisphosphonique combiné à de la vitamine d
JP5290198B2 (ja) * 2006-12-20 2013-09-18 ミラン ファーマシューティカルズ ユーエルシー ホットメルト顆粒化潤滑剤を含んでなる医薬組成物
TWI391150B (zh) * 2008-01-22 2013-04-01 Taiwan Biotech Co Ltd 腸溶性長效塗覆芯與藥物劑型及其製造方法
CN101756934A (zh) * 2008-12-10 2010-06-30 上海复星普适医药科技有限公司 文拉法辛缓释制剂的制备方法
KR101787481B1 (ko) 2010-10-21 2017-10-18 롯데정밀화학 주식회사 장용성 경질 캡슐용 조성물 및 상기 조성물을 사용하여 제조된 장용성 경질 캡슐
US9789093B2 (en) 2011-01-31 2017-10-17 Serotech, Llc Dosage regimen, medication dispensing package and uses thereof for the treatment of major depressive disorder
KR20180097581A (ko) 2015-12-25 2018-08-31 토야마 케미칼 컴퍼니 리미티드 1-(3-(2-(1-벤조티오펜-5-일)에톡시)프로필)아제티딘-3-올 또는 그 염을 포함하는 정제
KR102062052B1 (ko) * 2018-03-20 2020-01-03 일양약품주식회사 베타네콜 서방성 제제 및 이의 제조방법
KR20230067863A (ko) 2021-11-10 2023-05-17 박찬호 스마트 계량도구 및 이를 이용한 요리보조 시스템

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4153677A (en) * 1978-05-18 1979-05-08 Sterling Drug Inc. Controlled-release composition
US4535186A (en) 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
PE57198A1 (es) 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
US6274171B1 (en) * 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
UA77145C2 (en) 1997-11-05 2006-11-15 Wyeth Corp Extended release dosage formulation
CA2327285C (fr) * 1998-05-15 2005-06-14 Warner-Lambert Company Preparations pharmaceutiques stabilisees de derives d'acide gamma-aminobutyrique et procede de fabrication associe
ATE357910T1 (de) 1999-11-22 2007-04-15 Alza Corp Osmotische darreichungsform mit zwei mantelschichten
US6346269B1 (en) * 2000-05-08 2002-02-12 Standard Chem. & Pharm. Co., Ltd. Method for preparing an oral formulation containing acid-sensitive drugs and oral formulation made thereby
US6350471B1 (en) * 2000-05-31 2002-02-26 Pharma Pass Llc Tablet comprising a delayed release coating
CA2444569C (fr) * 2001-04-18 2011-01-04 Nostrum Pharmaceuticals Inc. Nouvel enrobage de composition pharmaceutique a liberation lente
US20030091634A1 (en) * 2001-09-14 2003-05-15 Pawan Seth Delayed release tablet of venlafaxin
EP1455751A1 (fr) 2001-12-20 2004-09-15 Pharmacia Corporation Formes dosifiees a liberation soutenue d'ordre zero et procede de production associe
EP1474123A1 (fr) * 2002-01-03 2004-11-10 LEK Pharmaceuticals D.D. Formulation pharmaceutique a liberation controlee contenant de la venlafaxine
AR039166A1 (es) * 2002-03-28 2005-02-09 Synthon Bv Composiciones de venlafaxina base
AR039164A1 (es) * 2002-03-28 2005-02-09 Synthon Bv Sales de venlafaxina de baja solubilidad en agua
IL149055A0 (en) * 2002-04-09 2002-11-10 Karma Pharm Ltd Extended release composition comprising as active compound venlafaxine hydrochloride
BR0312445A (pt) * 2002-06-07 2005-05-10 Ranbaxy Lab Ltd Sistemas multiunitários para disponibilização de fármaco de liberação modificada
US8216609B2 (en) 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
US7058999B2 (en) * 2002-10-24 2006-06-13 Paramount Bed Co., Ltd. Electric bed and control apparatus and control method therefor
US6703044B1 (en) * 2002-10-25 2004-03-09 Dexcel Pharma Tech, Ltd Venlafaxine formulations
EP1558222A2 (fr) * 2002-10-25 2005-08-03 Dexcel Pharma Technologies Ltd. Compositions pharmaceutiques renfermant de la venlafaxine
US20060246132A1 (en) * 2003-02-07 2006-11-02 Fjalar Johannsson Sustained release formulations of venlafaxine
SI1502587T1 (sl) * 2003-07-30 2007-02-28 Pharmathen Sa Formulacija z zadrzevanim sproscanjem za Venlafaxin hidroklorid
US7016014B2 (en) * 2004-02-27 2006-03-21 Asml Netherlands B.V Lithographic apparatus and device manufacturing method

Also Published As

Publication number Publication date
US20050169985A1 (en) 2005-08-04
IL177243A0 (en) 2006-12-10
JP2007520547A (ja) 2007-07-26
ATE361743T1 (de) 2007-06-15
CA2555295C (fr) 2011-01-18
AU2004315136B2 (en) 2010-06-17
UA82597C2 (uk) 2008-04-25
HK1091137A1 (en) 2007-01-12
CY1106741T1 (el) 2012-05-23
DK1711169T3 (da) 2007-09-17
NZ548504A (en) 2009-03-31
PT1711169E (pt) 2007-07-23
SI1711169T1 (sl) 2007-10-31
US7807195B2 (en) 2010-10-05
WO2005074895A1 (fr) 2005-08-18
NO20063809L (no) 2006-08-25
DE602004006443D1 (de) 2007-06-21
EP1711169A1 (fr) 2006-10-18
RU2340331C2 (ru) 2008-12-10
RU2006129034A (ru) 2008-03-10
EP1711169B1 (fr) 2007-05-09
PL1711169T3 (pl) 2007-10-31
MXPA06008854A (es) 2007-01-23
BRPI0418283A (pt) 2007-05-02
KR20070000439A (ko) 2007-01-02
DE602004006443T2 (de) 2008-01-10
AU2004315136A1 (en) 2005-08-18
CA2555295A1 (fr) 2005-08-18
ES2287813T3 (es) 2007-12-16

Similar Documents

Publication Publication Date Title
HRP20070353T3 (en) Extended release coated minitablets of venlafaxine hydrochloride
PL356962A1 (en) Multi-particulate form of medicament, comprising at least two differently coated forms of pellet
DE69917866D1 (de) Bupropionhydrochlorid enthaltende Tabletten mit gesteuerter Wirkstoffabgabe
HK1058482A1 (en) Taste masked pharmaceutical compositions
WO2008132712A3 (fr) Compositions pharmaceutiques combinées
MX2009004874A (es) Formulaciones farmaceuticas estratificadas que comprenden una capa intermediaria que se disuelve rapidamente.
ATE346591T1 (de) Pharmazeutische tablette
CY1107576T1 (el) Ταχεια αποδεσμευση των υδατοδιαλυτων φαρμακευτικων ουσιων
HK1070821A1 (en) Extended release venlafaxine tablet formulation
WO2005027843A3 (fr) Formes de dosage chronotherapeutique
CN103068375B (zh) 改善性能的片剂套管
JP2005532289A5 (fr)
MX2009008197A (es) Forma de dosificacion de liberacion extendida.
ES2185452A1 (es) Composicion farmaceutica de fluoxetina en comprimido dispersable recubierto y su proceso de fabricacion.
WO2004062552A3 (fr) Composition pharmaceutique contenant un ains et un derive benzimidazole
WO2007016350A3 (fr) Preparation en comprimes a liberation modifiee presentant des proprietes mecaniques ameliorees
WO2007129329A3 (fr) Préparation pharmaceutique à libération prolongée comprenant du chlorhydrate de venlafaxine
CA2448927A1 (fr) Composition pharmaceutique
WO2011159491A3 (fr) Formulations de lévétiracétam à libération contrôlée
TNSN06242A1 (en) Extended release coated minitablets of venlafaxine hydrochloride
CA2421240A1 (fr) Preparations de granules pour administration orale
MX2023004418A (es) Capsulas de gel blando de liberacion modificada.
BR0109640A (pt) Forma de droga multiparticulada compreendendo pelo menos duas formas de pélete diferentemente revestidas
WO2005102273A3 (fr) Compositions pharmaceutiques a base d'un biguanide et d'une sulfonyluree
RS53364B (en) STABLE LIQUID PHARMACEUTICAL FORMULATION